Products
News
Resources
Contact
Language
简体中文
繁體中文
English
日本語
한국어
Tiếng Việt
VIVA BIOTECH HOLDINGS / PORDA HAVAS
{{company.company_channel.channel_name}}
Media Room
Latest
{{company.company_name_local}}
{{company.company_channel.channel_name}}
Follow :
X
Company Profile
Media Room
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.title}}
loading
The End
Network Errors Please Retry
{{selectname}}
{{showName}}
{{selectall}}
{{option}}
Viva Biotech Launches the AI-Driven Drug Discovery Platform, Transforming New Drug R&D Logic, Enabling One-Stop Innovative Drug Discovery
2025-05-15 15:02
Viva Biotech's Wholly-Owned Subsidiary Langhua Pharmaceutical Successfully Passes U.S. FDA On-Site Inspection
2025-03-28 15:46
Viva Biotech Announces 2024 Annual Results: Significantly Rebounding in Performance with New Stage ahead, AI Leads to a New Era of Novel Drug R&D
2025-03-27 21:35
Latest Updates of Viva Biotech's Portfolio Companies
2025-01-08 20:19
Viva Biotech Officially Establishes Boston Branch, Marking Another Milestone in Global Expansion
2024-12-11 14:44
Latest Updates of Viva Biotech's Portfolio Companies
2024-10-30 22:24
Viva Biotech Announces Its 2024 Interim Results: Significant Improvement in Net Profit Growth and Ongoing Optimization of Emerging Technology Platforms
2024-08-29 20:42
Latest Updates of Viva Biotech's Portfolio Companies
2024-08-06 18:47
Latest Updates of Viva Biotech's Portfolio Companies
2024-06-12 19:51
Latest Updates of Viva Biotech's Portfolio Companies
2024-06-12 19:51
Viva Biotech (1873.HK) Announces 2023 Annual Results: Successful Implementation of Light-asset Strategy, Achieving Solid Growth and Promising Future
2024-03-28 22:46
Latest Updates of Viva Biotech's Portfolio Companies
2024-03-06 19:33
Latest Updates of Viva's Portfolio Companies
2023-12-04 17:55
Viva Biotech Secures Approximately US$ 210 Million Funding
2023-11-20 20:04
Latest Updates of Viva's Portfolio Companies
2023-09-26 21:06
Viva Biotech (1873.HK) Announces 2023 Interim Results:Solid Growth in Main Business, Significant Rebound in Profitability
2023-08-29 22:38
Latest Updates of 7 Viva's Portfolio Companies
2023-07-28 19:31
Viva Biotech's Portfolio Company Riparian Pharmaceuticals Announces Exclusive License Agreement and Research Agreement with Pfizer for Novel Cardiovascular Programs
2023-07-20 19:15
Viva Biotech's Portfolio Company DTx Pharma Reached the Acquisition Agreement with Novartis
2023-07-18 15:00
Latest Updates of 9 Viva's Portfolio Companies
2023-06-02 18:51
1
2